Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | PRKCA | P17252 | 6/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11439112 | 0.92 | NAAA (0.38) | NAAAPRKCA | |
| SCHEMBL11532132 | 0.90 | DGKA (0.43) | NAAAPRKCAEPHX2DGKA | |
| SCHEMBL11666975 | 0.89 | PRKCA (0.34) | NAAAPRKCA | |
| SCHEMBL11535520 | 0.86 | NAAA (0.43) | NAAAPRKCAARNLRP3DGKA | |
| SCHEMBL11532950 | 0.85 | TSHR (0.39) | NAAAPRKCAARNLRP3DGKA | |
| SCHEMBL11533780 | 0.84 | PRKCA (0.38) | NAAAPRKCA | |
| SCHEMBL4796611 | 0.84 | NAAA (0.43) | NAAAPRKCAARNLRP3DGKA | |
| SCHEMBL4804143 | 0.84 | NAAA (0.43) | NAAAPRKCAARNLRP3DGKA | |
| SCHEMBL4804134 | 0.84 | NAAA (0.43) | NAAAPRKCAARNLRP3DGKA | |
| SCHEMBL4796615 | 0.84 | NAAA (0.43) | NAAAPRKCAARNLRP3DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4141883-A | Stabilization of synthetic polymers by penta-or-hexa-substituted 4-piperidinol derivatives | SANKYO COMPANY, LIMITED (JP) | 1979-02-27 | — | — | US | disclosed |
| US-4075165-A | 2,2,6,6-TETRA-SUBSTITUTED-4-PIPERIDINOL | CIBA-GEIGY CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |